Thursday, 6 Aug 2026
Subscribe
States Top Leading News States Top Leading News
  • Home
  • Videos
  • Categories
    • Local News
    • Editorial
    • Business
    • Education
    • Entertainment
    • Finance
    • General
    • Lifestyle
    • Health
    • Technology
    • Politics
    • World
    • Press Releases
    • Shop
  • Services
    • Submit Guest Posts
    • Press Release Distribution
    • Biz Directory
    • Video Press Release
  • Career
  • Donate
    • GoFundMe
  • About
    • Domain Authority
    • Disclaimer Page
    • Staff Directory
    • Published Pages
    • Investor Inquiries
    • Contact
Font ResizerAa
STL.NewsSTL.News
Search
  • Home
  • Videos
  • Categories
    • Local News
    • Editorial
    • Business
    • Education
    • Entertainment
    • Finance
    • General
    • Lifestyle
    • Health
    • Technology
    • Politics
    • World
    • Press Releases
    • Shop
  • Services
    • Submit Guest Posts
    • Press Release Distribution
    • Biz Directory
    • Video Press Release
  • Career
  • Donate
    • GoFundMe
  • About
    • Domain Authority
    • Disclaimer Page
    • Staff Directory
    • Published Pages
    • Investor Inquiries
    • Contact
Have an existing account? Sign In
Follow US
© States Top Leading News. All Rights Reserved.

Home » Business » Sanjay Kumar – Charged – Selling Counterfeit Cancer Drugs

Business

Sanjay Kumar – Charged – Selling Counterfeit Cancer Drugs

Smith
Last updated: July 28, 2024 8:03 am
Smith - Editor in Chief
Share
Sanjay Kumar - Charged - Selling Counterfeit Cancer Drugs
Sanjay Kumar - Charged - Selling Counterfeit Cancer Drugs
SHARE

Foreign National, Sanjay Kumar, Charged for Selling Counterfeit Cancer Drugs.

(STL.News) A federal grand jury in Houston, Texas, returned an indictment on July 25, 2024, charging an Indian national, Sanjay Kumar, with shipping and selling tens of thousands of dollars worth of counterfeit oncology pharmaceuticals into the United States.

According to court documents, Sanjay Kumar, 43, of Bihar, India, and his co-conspirators allegedly arranged for the sale and shipment of fake, counterfeit versions of oncology pharmaceuticals—including Keytruda—to individuals in the United States.  Genuine Keytruda is a cancer immunotherapy that is approved in the United States for 19 different indications, including to treat certain types of melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, gastric cancer, cervical cancer, and breast cancer.  Merck Sharp & Dohme LLC, formerly known as Merck Sharp & Dohme Corp., has the exclusive right to authorize the manufacture of Keytruda for introduction into interstate commerce.

Sanjay Kumar was arrested on June 26 in Houston after traveling to the United States to conduct further negotiations aimed at expanding his business selling fake Keytruda in the U.S. market.

Sanjay Kumar is charged with one count of conspiracy to traffic in counterfeit drugs and four counts of trafficking in counterfeit drugs.  If convicted, he faces a maximum penalty of 20 years in prison on each count.

Principal Deputy Assistant Attorney General Nicole M. Argentieri, head of the Justice Department’s Criminal Division; U.S. Attorney Alamdar Hamdani for the Southern District of Texas; Special Agent in Charge Mark Dawson of Homeland Security Investigations (HSI) Houston; and Special Agent in Charge Charles Grinstead of the Food and Drug Administration’s (FDA) Office of Criminal Investigations, Kansas City Field Office made the announcement.

HSI and the FDA investigated the case.

Trial Attorneys Jeff Pearlman and Bryce Rosenbower of the Criminal Division’s Computer Crime and Intellectual Property Section and Assistant U.S. Attorney Jay Hileman for the Southern District of Texas are prosecuting the case.

An indictment is merely an allegation.  All defendants are presumed innocent until proven guilty beyond a reasonable doubt in a court of law.

SOURCE: DOJ

TAGGED:Texas
Share This Article
Twitter Email Copy Link Print
By Smith Editor in Chief
Follow:
Martin W. Smith is the founder and Editor-in-Chief of a digital media network that includes STL.News, STL.Directory, St. Louis Restaurant Review, STLPress.News, USPress.News, and more. Managing a global publishing team, Smith oversees editorial strategy and content curation across the entire network. To support this high-volume operation, he engineered a proprietary RSS aggregation infrastructure capable of importing, managing, and filtering thousands of daily press releases. Since its launch in February 2016, STL.News has published more than 250,000 articles. Smith is a member of the United States Press Agency (Reg. #31659) and a certified member of the US Press Association (Reg. #802085479).
Best Webhost

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.
FacebookLike
TwitterFollow
PinterestPin
InstagramFollow
Google NewsFollow
LinkedInFollow

Popular Posts

Reliance Staffing of Michigan to Pay $181K in Back Wages

The U.S. Department of Labor Recovered $181K for 70 Nurses and assistants who were Denied…

By Smith

Man apprehended in unusual Lafayette murder following mysterious online messages.

Headline: Lafayette Man Arrested in Unusual Homicide Case In a shocking turn of events, a…

By Smith
Business Loans
States Top Leading News States Top Leading News
Facebook Twitter Pinterest Apple Google

About STL.News

Boost your brand with STL.News. Publish high-impact Press Releases and secure essential local Business Directory Listings to maximize your online visibility, reach target audiences instantly, and drive powerful growth across St. Louis and beyond, and connect with more loyal customers. Visit our Google Listing or visit our Google News page.

  • Marty@STLMedia.Agency
  • 417-529-1133
  • 36 Four Seasons Shopping Center # 310 Chesterfield, Missouri 63017 United States

© Copyright 2026 – St. Louis Media LLC dba STL.News – All Rights Reserved.

adbanner
AdBlock Detected
Our site is an advertising supported site. Please whitelist to support our site.
Okay, I'll Whitelist
Welcome Back!

Sign in to your account

Lost your password?